Because clinical ulcerative colitis patients are often complicated with pathogenic bacteria infection, enterotoxigenic Escherichia coli (ETEC) was introduced to aggravate intestinal inflammation in mice, better simulate the condition of clinical ulcerative colitis patients, and further explore the efficacy and possible mechanism of GLP-2 in the treatment of UC. The gene discussed is GCG; the disease is ulcerative colitis.